Taysha Gene Therapies, Inc. Common Stock
$4.67
▼ 0.12
(-2.50%)
Volume: 3,100,965
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
15
- 21d momentum -22.4%
- MA aligned bearish
- RSI 29 oversold
🎯
Pullback
68
- RSI 29 near lows
- Near lower Bollinger band
- -10.9% vs 20MA
💎
Value
58
- -36% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)28.8
MACD-0.031
MA trendBearish
ATR5.78%
21d mom.-22.4%
63d mom.-26.3%
vs 20MA-10.9%
RVOL(20)0.92×
52w low · 3
52w high · 7
-36.0% from 52-week high
20d support 5
· resistance 6
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$1.6B
PER—
PBR4.03
PSR284.55
EPS$-0.46
ROE-38.6%
ROA-31.8%
Dividend yield0.00%
Debt/Equity0.13
EV/EBITDA-7.43
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -6.97% | -22.43% | -26.34% | +8.10% | +48.25% | -11.05% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -16.61%, daily vol 2.40%. Taysha Gene Therapies, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.